Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Join | Sign in
Home>Videos>This Video
  Videos

Return

sciFLEXARRAYER - ultra-low volume dispensing systems for R and D and manufacturing
Scienion AG

sciFLEXARRAYER drop-on-demand, inkjet-printing instruments are made for automated ultra-low-volume liquid-handling of biological samples such as DNA, proteins, antibodies and even whole cells. Organic solvents based samples, nano-particles and many other liquids can be handled too. Typical applications are the manufacturing of biosensors, loading of MALDI targets and printing of microarrays, e.g. directly at the bottom of microtiter-plate wells. These microarrays are made of e.g. DNA, proteins, antibodies and glycans, as well as from antigens of different sources for allergy-testing. In order to meet the brought variety of needs of our customers from early research to high-throughput manufacturing, Scienion offers tailor-made systems of different sizes and throughput, ranging from the basic S1 over S3, S5, S11 and SX to the ultimate tool for high-performance manufacturing, the S100.

Request more information
Company product page


Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
What Causes Immune Cell Migration To Wounds
Study shows triggers which lead immune cells to react and respond to wounded sites.
Starting Antiretroviral Treatment Early Improves Outcomes for HIV-infected Individuals
NIH-funded trial results likely will impact global treatment guidelines.
Viral Immunotherapy For Skin Cancer Shows Patient Benefit
A genetically engineered herpes virus can halt the progression of skin cancer by killing cancer cells and sparking the immune system into action against tumours, a landmark clinical trial has shown.
How Hep C Survives Immune System Attacks
Using mathematical modelling researchers have uncovered the tactics employed by the Hep C in order to avoid the immune system.
Baylor, TGen Collaborate on Personalized Cancer Treatment Options
The companies will collaborate on precision medicine for cancer patients by offering liquid biopsies, performing gene sequencing, conducting clinical trials, and creating personalized vaccines.
Freshly Squeezed Vaccines
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
New Target for Treating Rheumatoid Arthritis
Many affected individuals still suffer with progressive joint damage, despite treatment. This study has discovered a new treatment target which could open a door to preventing this ongoing damage.
Shining A New Light On The Immune System
Scientists at the University of St Andrews have developed a revolutionary method of identifying cells of the immune system with “molecular fingerprints” which could pave the way for the rapid detection of conditions such as leukaemia and lymphoma from a small blood sample.
Promising Malaria and Dengue Vaccines Will Not Defeat Diseases
Although vaccination is a key part of the control of disease GlobalData stress the importance of a multi-dimensional approach.
'Redesigned' Antibodies May Neutralize HIV
With the help of a new computer program researchers have made structural alterations to an antibody, increasing its ability to tackle the AIDS virus.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters